Back
UMB Financial Vs. Akero Therapeutics Industry Stock Comparison
Sell
49
UMBF
UMB Financial
Last Price:
83.18
Seasonality Move:
2.65%
Sell
32
AKRO
Akero Therapeutics
Last Price:
19.72
Seasonality Move:
16.15%
Sell
49
UMB Financial (UMBF)
is a Sell
Is UMB Financial a Buy, Sell or Hold?
- The current UMB Financial [UMBF] share price is $83.66. The Score for UMBF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- UMBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $18.93. The Score for AKRO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UMBF Stock Price Chart
What is UMB Financial's stock price today?
-
The UMB Financial share price today is $83.66
The current trend is moderately bullish and UMBF is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $18.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
UMBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 55.86 | Buy |
| Chaikin Money Flow: | 74156 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.61 - 84.55) | Buy |
| Bollinger Bands (100): | (78.89 - 83.65) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.33 | Sell |
| Relative Strength Index (14 RSI): | 26.69 | Sell |
| Chaikin Money Flow: | -152705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.92 - 24.38) | Sell |
| Bollinger Bands (100): | (20.07 - 26.07) | Sell |
UMBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.09 | Buy |
| 20-day SMA: | 82.54 | Buy |
| 50-day SMA: | 81.77 | Buy |
| 200-day SMA: | 73.43 | Buy |
| 8-day EMA: | 82.82 | Buy |
| 20-day EMA: | 82.29 | Buy |
| 50-day EMA: | 81.66 | Buy |
| 200-day EMA: | 76.58 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.71 | Sell |
| 20-day SMA: | 22.11 | Sell |
| 50-day SMA: | 24.62 | Sell |
| 200-day SMA: | 28.95 | Sell |
| 8-day EMA: | 20.61 | Sell |
| 20-day EMA: | 21.98 | Sell |
| 50-day EMA: | 23.22 | Sell |
| 200-day EMA: | 27.52 | Sell |
UMB Financial Earnings Growth & UMBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.33 per share, and an increase next year of $0.45 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
UMB Financial Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||